Search - tctmd.com

Displaying 561 - 580 of 591

Sort: Relevancy | Date

News Daily News

JAMA Review Tackles Intricacies of Medical Therapy After PCI

Caitlin E. Cox

July 11, 2013

News Conference News SCAI 2013

ACC/AHA/SCAI Statement: Volume Not the Sole Arbiter of Quality PCI

Caitlin E. Cox

May 10, 2013

News Daily News

Imaging Detects Vascular Injury Arising from Catheter-Based Renal Denervation

Caitlin E. Cox

May 03, 2013

News Daily News

ESC Offers Recommendations on Use of New Oral Anticoagulants

Yael L. Maxwell

May 03, 2013

News Industry News

FDA Advisory Committee Votes Favorably on Abbott's Minimally Invasive MitraClip® Device for Patients with Significant Mitral Regurgitation Who Are Too High Risk for Surgery

March 20, 2013

News Daily News

Women vs. Men in BARI 2D: Equal Survival but Worse Quality of Life

March 09, 2013

News Daily News

No Long-term Mortality Difference Between Endovascular vs. Open AAA Repair

Caitlin E. Cox

November 25, 2012

News Conference News TCT 2012

PARTNER Shows Continued Benefits of TAVR, but STACCATO Introduces Questions About Transapical Use

October 23, 2012

News Industry News

Analysis Of Medtronic Stent Finds Early Cessation Of Dual Antiplatelet Therapy Caused No Increased Risk Of Blood Clots To One Year

October 22, 2012

News Conference News ESC 2012

ESC Congress 2012 Offers Slate of Guidelines, New MI Definition

Caitlin E. Cox

August 26, 2012

News Daily News

FDA Label Change Fails to Stem Uncertainty Over PPI Use with Clopidogrel

Caitlin E. Cox

May 09, 2012

News Features

FDA Label Change Fails to Stem Uncertainty Over PPI Use with Clopidogrel

Caitlin E. Cox

May 07, 2012

News Daily News

New York State Public Reporting on PCI Mortality Does Little to Change Behavior

Caitlin E. Cox

January 12, 2012

News Conference News

Supervised Exercise Improves Walking Outcomes Better Than Stenting in PAD

November 16, 2011

News Conference News

STACCATO: Transapical TAVR Inferior to Surgery for Operable Elderly Patients

November 09, 2011

News Conference News

PARIS: Early DAPT Nonadherence, A Small Problem with Big Consequences

November 09, 2011

News Industry News

Clinical trial that compared transapical transcatheter aortic valve replacement to surgical aortic valve replacement

November 09, 2011

News Conference News

TAVR Bioprosthesis Safe, Effective at 1 Year

November 07, 2011

News Daily News

First DES for Above-the-Knee Vascular Disease on the Horizon

L.A. McKeown

October 18, 2011

News Daily News

Interruption of Antiplatelet Therapy Unnecessary for Tooth Extraction

July 27, 2011

Advertisement

JAMA Review Tackles Intricacies of Medical Therapy After PCI

ACC/AHA/SCAI Statement: Volume Not the Sole Arbiter of Quality PCI

Imaging Detects Vascular Injury Arising from Catheter-Based Renal Denervation

ESC Offers Recommendations on Use of New Oral Anticoagulants

FDA Advisory Committee Votes Favorably on Abbott's Minimally Invasive MitraClip® Device for Patients with Significant Mitral Regurgitation Who Are Too High Risk for Surgery

Women vs. Men in BARI 2D: Equal Survival but Worse Quality of Life

No Long-term Mortality Difference Between Endovascular vs. Open AAA Repair

PARTNER Shows Continued Benefits of TAVR, but STACCATO Introduces Questions About Transapical Use

Analysis Of Medtronic Stent Finds Early Cessation Of Dual Antiplatelet Therapy Caused No Increased Risk Of Blood Clots To One Year

ESC Congress 2012 Offers Slate of Guidelines, New MI Definition

FDA Label Change Fails to Stem Uncertainty Over PPI Use with Clopidogrel

FDA Label Change Fails to Stem Uncertainty Over PPI Use with Clopidogrel

New York State Public Reporting on PCI Mortality Does Little to Change Behavior

Supervised Exercise Improves Walking Outcomes Better Than Stenting in PAD

STACCATO: Transapical TAVR Inferior to Surgery for Operable Elderly Patients

PARIS: Early DAPT Nonadherence, A Small Problem with Big Consequences

Clinical trial that compared transapical transcatheter aortic valve replacement to surgical aortic valve replacement

TAVR Bioprosthesis Safe, Effective at 1 Year

First DES for Above-the-Knee Vascular Disease on the Horizon

Interruption of Antiplatelet Therapy Unnecessary for Tooth Extraction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content